ANL 21.10 Increased By ▲ 0.25 (1.2%)
ASC 13.25 Decreased By ▼ -0.29 (-2.14%)
ASL 22.90 Decreased By ▼ -0.10 (-0.43%)
BOP 8.21 Increased By ▲ 0.01 (0.12%)
BYCO 7.80 Decreased By ▼ -0.01 (-0.13%)
FCCL 17.50 Decreased By ▼ -0.30 (-1.69%)
FFBL 23.00 Increased By ▲ 0.25 (1.1%)
FFL 15.70 Increased By ▲ 0.20 (1.29%)
FNEL 7.33 Decreased By ▼ -0.02 (-0.27%)
GGGL 17.31 Decreased By ▼ -0.52 (-2.92%)
GGL 38.60 Decreased By ▼ -1.41 (-3.52%)
HUMNL 5.92 Decreased By ▼ -0.10 (-1.66%)
JSCL 18.40 Increased By ▲ 0.10 (0.55%)
KAPCO 36.21 Decreased By ▼ -0.14 (-0.39%)
KEL 3.41 Increased By ▲ 0.01 (0.29%)
MDTL 2.56 Decreased By ▼ -0.09 (-3.4%)
MLCF 34.70 Decreased By ▼ -0.40 (-1.14%)
NETSOL 124.01 Decreased By ▼ -5.39 (-4.17%)
PACE 4.76 Increased By ▲ 0.01 (0.21%)
PAEL 27.32 Increased By ▲ 0.32 (1.19%)
PIBTL 8.76 Decreased By ▼ -0.09 (-1.02%)
POWER 7.35 Decreased By ▼ -0.10 (-1.34%)
PRL 17.22 Increased By ▲ 0.07 (0.41%)
PTC 9.89 Decreased By ▼ -0.12 (-1.2%)
SILK 1.48 Decreased By ▼ -0.02 (-1.33%)
SNGP 45.51 Increased By ▲ 0.51 (1.13%)
TELE 17.48 Decreased By ▼ -1.41 (-7.46%)
TRG 164.00 Increased By ▲ 1.30 (0.8%)
UNITY 33.30 Increased By ▲ 0.35 (1.06%)
WTL 2.91 Decreased By ▼ -0.03 (-1.02%)
BR100 4,747 Increased By ▲ 13.42 (0.28%)
BR30 22,775 Decreased By ▼ -27.45 (-0.12%)
KSE100 45,279 Decreased By ▼ -17.81 (-0.04%)
KSE30 17,822 Increased By ▲ 11.44 (0.06%)

Coronavirus
VERY HIGH Source: covid.gov.pk
Pakistan Deaths
27,482
5024hr
Pakistan Cases
1,234,828
2,23324hr
4.23% positivity
Sindh
453,858
Punjab
426,639
Balochistan
32,828
Islamabad
104,764
KPK
172,498

Oxford vaccine

Britain recommends not using Oxford/AstraZeneca vaccine for under-30s
World

Britain recommends not using Oxford/AstraZeneca vaccine for under-30s

  • "We are not advising a stop to any vaccination for any individual in any age group. We are advising a preference for one vaccine over another vaccine for a particular age group, really out of the utmost caution, rather than because we have any serious safety concerns," he said at a briefing. It came after Britain's MHRA medicine regulator identified a possible side-effect from the COVID-19 vaccine developed by Oxford University and AstraZeneca involving rare brain blood clotting.
Published 07 Apr, 2021 08:09pm
AstraZeneca/Oxford vaccine more effective with longer dose gap: study
Business & Finance

AstraZeneca/Oxford vaccine more effective with longer dose gap: study

  • The study confirmed the Anglo-Swedish drugmaker's findings from earlier this month that showed the vaccine had 76% efficacy against symptomatic coronavirus infection for three months after the first dose.
  • Efficacy was found to be at 81% with the longer interval of 12 weeks between the first and second dose, compared with 55% efficacy up to the six-week gap.
Published 19 Feb, 2021 09:17pm
South Africa offers AstraZeneca jabs to AU
World

South Africa offers AstraZeneca jabs to AU

  • "The first batch of Johnson & Johnson Covid-19 vaccines have arrived at OR Tambo International Airport," Mkhize tweeted as the precious cargo landed in the financial capital Johannesburg.
Published 17 Feb, 2021 11:06am